Mithrl is a San Francisco, CA-based provider of an AI-powered platform designed to empower scientific research and accelerate discovery. The system, now available, is targeted at pharmaceutical companies, biotech firms, and research institutions seeking to speed up drug discovery. Mithrl’s platform can process and analyze RNA sequencing data in minutes with no training or coding required. It exposes the underlying code, methodology, and data transformations so scientists can validate each step and build confidence in the platform’s findings. Led by CEO Vivek Adarsh and CTO Shara Balakrishnan, the company plans to use the funds to expand its go-to-market team and further develop the platform. The company announced a $4M Seed round in November 2024.

Total raised

$4M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2024